• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[FTY720在慢性结肠炎中的额外作用]

[An additional role of FTY720 in chronic colitis].

作者信息

Fujii Toshimitsu, Watanabe Mamoru

机构信息

Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University.

出版信息

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):7-14. doi: 10.2177/jsci.32.7.

DOI:10.2177/jsci.32.7
PMID:19252372
Abstract

FTY720 is a sphingosine-1-phosphate receptor modulator, which inhibits T-cell egress from lymph nodes, thereby prevents pathogenic T cells from migrating towards disease sites. In inflammatory bowel diseases, it is thought that colitogenic memory CD4+ T cells are intermittently reactivated in regional lymphoid organs, and return to inflammatory tissues. Little is known about how FTY720 controls the migration property of memory T cells and whether FTY720 could control the trafficking of T cells without the presence of lymphoid tissues. First, we here demonstrated that FTY720 prevents the development of colitis induced by the adoptive transfer of colitogenic lamina propria effector-memory CD4+ T (T(EM)) cells into SCID mice. Next, We demonstrated that FTY720 treatment suppresses the recirculation of CD4(+) T cells in splenectomized lymphotoxin-alpha(-/-) mice that lack lymph nodes and spleen. Cell number of CD4+ T cells was markedly decreased in peripheral blood of FTY720-treated mice, but conversely increased in bone marrow. Notably, FTY720 treatment prevented the development of colitis induced by transfer of colitogenic T(EM) cells into SPX LT-a(-/-) x RAG-2(-/-) mice. Collectively, the present data indicate that FTY720 treatment may offer an additional role to direct trafficking of CD4+ T cells in BM, resulting in the prevention of memory T cell-mediated diseases including inflammatory bowel diseases.

摘要

FTY720是一种鞘氨醇-1-磷酸受体调节剂,它可抑制T细胞从淋巴结逸出,从而防止致病性T细胞向疾病部位迁移。在炎症性肠病中,人们认为致结肠炎记忆CD4+ T细胞在区域淋巴器官中会间歇性地重新激活,并返回炎症组织。关于FTY720如何控制记忆T细胞的迁移特性以及FTY720在没有淋巴组织的情况下是否能够控制T细胞的运输,目前所知甚少。首先,我们在此证明FTY720可预防因将致结肠炎固有层效应记忆CD4+ T(T(EM))细胞过继转移至SCID小鼠而诱发的结肠炎。接下来,我们证明FTY720处理可抑制在缺乏淋巴结和脾脏的脾切除淋巴毒素-α(-/-)小鼠中CD4(+) T细胞的再循环。在接受FTY720处理的小鼠外周血中,CD4+ T细胞数量显著减少,但在骨髓中则相反增加。值得注意的是,FTY720处理可预防因将致结肠炎T(EM)细胞转移至SPX LT-a(-/-) x RAG-2(-/-)小鼠而诱发的结肠炎。总体而言,目前的数据表明FTY720处理可能在直接控制CD4+ T细胞在骨髓中的运输方面发挥额外作用,从而预防包括炎症性肠病在内的记忆T细胞介导的疾病。

相似文献

1
[An additional role of FTY720 in chronic colitis].[FTY720在慢性结肠炎中的额外作用]
Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):7-14. doi: 10.2177/jsci.32.7.
2
FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.FTY720通过调节致结肠炎CD4+ T细胞在骨髓中的运输,抑制无淋巴细胞小鼠结肠炎的发展。
Eur J Immunol. 2008 Dec;38(12):3290-303. doi: 10.1002/eji.200838359.
3
FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.FTY720抑制CD4+CD44高表达CD62L低表达效应记忆T细胞介导的结肠炎。
Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G267-74. doi: 10.1152/ajpgi.00496.2005. Epub 2006 Mar 30.
4
Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.FTY720 尽管有效调节血液 T 细胞,但在 NOD.scid 转移模型中仅能预防、而非治疗自身免疫性糖尿病。
Autoimmunity. 2011 Mar;44(2):115-28. doi: 10.3109/08916934.2010.499885. Epub 2010 Aug 9.
5
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.鞘氨醇-1-磷酸(S1P)受体调节剂FTY720可预防小鼠实验性结肠炎的发生。
Oncol Rep. 2006 Oct;16(4):699-703.
6
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.FTY720通过直接影响CD4+CD25+调节性T细胞的功能活性来改善小鼠Th1介导的结肠炎。
J Immunol. 2007 Feb 15;178(4):2458-68. doi: 10.4049/jimmunol.178.4.2458.
7
Colitogenic CD4+ effector-memory T cells actively recirculate in chronic colitic mice.致结肠炎的CD4+效应记忆T细胞在慢性结肠炎小鼠中积极再循环。
Inflamm Bowel Dis. 2008 Dec;14(12):1630-40. doi: 10.1002/ibd.20636.
8
FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.FTY720优先从外周和淋巴器官中清除初始T细胞。
Int Immunopharmacol. 2006 Dec 20;6(13-14):1902-10. doi: 10.1016/j.intimp.2006.07.030. Epub 2006 Aug 30.
9
Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.保留致结肠炎CD4+T细胞的骨髓可能是慢性结肠炎的致病储存库。
Gastroenterology. 2007 Jan;132(1):176-89. doi: 10.1053/j.gastro.2006.10.035. Epub 2006 Oct 25.
10
Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.FTY720 介导的胰岛周三级淋巴器官稳定化预防糖尿病。
Diabetes. 2010 Jun;59(6):1461-8. doi: 10.2337/db09-1129. Epub 2010 Mar 18.